ADVFN US – Market Content Editor
-
NWTN shares climb 2.6% after $100 million injection from UAE investor
NWTN Inc. (NASDAQ:NWTN) saw its stock rise 2.6% following the announcement of a $100 million investment from SEET LLC, a subsidiary of the UAE-based investment firm Medad Holding. Through this deal, SEET will purchase newly issued shares, becoming the largest single shareholder in the NASDAQ-listed company. The partnership also includes plans for joint strategic efforts…
-
BlackSky shares climb 3.5% after securing Latin American defense monitoring deal
BlackSky Technology Inc (NYSE:BKSY) saw its stock increase by 3.5% following news of a new contract to supply subscription-based geospatial monitoring services to defense and intelligence agencies across Latin America. The company, specializing in geospatial intelligence, will provide On-Demand Gen-3 and Gen-2 satellite surveillance tools aimed at tackling transnational organized crime in the region. Through…
-
Ralph Lauren shares climb to record $295.86, fueled by strong gains and upbeat analyst sentiment
Ralph Lauren Corp (NYSE:RL) Class A stock soared to an all-time peak of $295.86, marking a key milestone for the iconic fashion brand. Over the past 12 months, the shares have surged over 75%, underscoring growing investor confidence and the company’s solid market execution. This milestone highlights Ralph Lauren’s resilience and adaptability amid evolving industry…
-
Vox Royalty shares edge up following Binduli North gold project expansion approval
Vox Royalty Corp. (NASDAQ:VOXR) saw its stock rise 1.2% after receiving regulatory clearance for a substantial expansion at the Binduli North gold project in Western Australia, where Vox holds an uncapped production royalty. Norton Gold Fields (NYSE:GFI), part of Zijin Mining Group, secured approval to boost crushing and grinding capacity by 40%, raising throughput to…
-
Ikena Oncology shares climb as Kristin Yarema named CEO of soon-to-merge ImageneBio
Shares of Ikena Oncology Inc. (NASDAQ:IKNA) rose 4.8% after the company announced that Kristin Yarema, Ph.D., will lead the soon-to-be-formed ImageneBio, Inc. as Chief Executive Officer, following the completion of its merger with Inmagene Biopharmaceuticals. The leadership appointment comes shortly after Ikena shareholders approved the merger on July 15, 2025. The transaction, which includes a…
-
Pharvaris shares slide following $175 million equity offering
Shares of Pharvaris N.V. (NASDAQ:PHVS) declined by 9.6% after the clinical-stage biopharmaceutical firm announced the pricing of a public stock offering aimed at raising approximately $175 million in gross proceeds. The offering includes 8.25 million ordinary shares priced at $20.00 each, along with pre-funded warrants for the purchase of 500,000 shares at $19.99 apiece, issued…
-
Veea shares dip after unveiling new stock and warrant issuance plan
Veea Inc. (NASDAQ:VEEA) saw its shares fall by 2.4% after the company announced plans to raise capital through a new offering of common stock and warrants, using a “reasonable best efforts” approach. The edge computing and smart network technology provider intends to issue a to-be-determined number of common shares, each paired with warrants allowing investors…
-
Lion Group shares climb as company boosts crypto reserves with fresh SUI token purchase
Shares of Lion Group Holding Ltd (NASDAQ:LGHL) surged 10.6% after the company revealed a significant expansion of its cryptocurrency holdings, notably adding more SUI tokens to its digital asset treasury, which now totals approximately $9.6 million in value. As of July 23, 2025, the company reported holding 1,015,680 Sui (SUI) tokens, along with 128,929 Hyperliquid…
-
Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test
Shares of Castle Biosciences Inc (NASDAQ:CSTL) rose 7.8% after the company announced that its DecisionDx-Melanoma test has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The diagnostic test, which analyzes gene expression, is designed to offer personalized insights for patients with stage I-III cutaneous melanoma. It aids clinicians in tailoring post-diagnosis…
-
Humacyte shares climb 6% after first Symvess sale to U.S. military hospital
Shares of Humacyte Inc (NASDAQ:HUMA) rose 6.1% after the company announced its first commercial sale of Symvess to a U.S. Military Treatment Facility. The sale was made to a major military medical center located on a large U.S. base, which provides care to around 200,000 active-duty personnel, veterans, and their families. The milestone follows Symvess’s…